C4 Therapeutics Inc. – Filings and Transcripts

NASDAQ: CCCC
Share price (7/6/26): $4.14
Market cap (7/6/26): $458 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement for primary offering

Free writing prospectus

Ownership Filter

Grogan Donna Roy

Anderson Kenneth Carl

Hoerter Steven L.

News Filter

Shareholder Vote Results, Financial Statements or Exhibits

Investor Presentation

Change in Directors, Officers or Compensation

Reports First Quarter 2026 Financial Results and Recent Business Highlights

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Notice of effectiveness